AC-46462 - dapagliflozin | 461432-26-8
Lamentamos, não foi encontrado nenhum produto com a referência AC-46462, mas por favor, verifique os seguintes produtos semelhantes:
Dapagliflozin
CAS:Fórmula:C21H25ClO6Pureza:≥ 98.0% (dried basis)Cor e Forma:White to light-yellow powderPeso molecular:408.87Dapagliflozin
CAS:Fórmula:C21H25ClO6Pureza:>95.0%(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:408.88Dapagliflozin
CAS:Dapagliflozin (BMS-512148) is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity.Fórmula:C21H25ClO6Pureza:99.5% - 99.93%Cor e Forma:SolidPeso molecular:408.87Ref: TM-T2389
5mg49,00€10mg64,00€25mg81,00€50mg89,00€100mg113,00€200mg150,00€1500mg284,00€1mL*10mM (DMSO)50,00€Ref: 10-F794039
1gA consultar5gA consultar10gA consultar25gA consultar100gA consultar10mgA consultar50mgA consultar100mgA consultar250mgA consultarDapagliflozin
CAS:<p>Stability Hygroscopic<br>Applications A sodium-glucose transporter 2 inhibitor.<br>References Kasichayanula, S. et al.: Diabetes, Obesity and Metabolism 13, 47 (2011)<br></p>Fórmula:C21H25ClO6Cor e Forma:NeatPeso molecular:408.87Dapagliflozin
CAS:Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. SGLT2 is located in the proximal convoluted tubule and when it is inhibited the reabsorption of glucose into the kidneys is prevented and instead glucose is excreted in the urine. As a result glucose levels are reduced. Dapagliflozin is metabolized into to its inactive metabolite 3-O-glucuronide by the UGT1A9 enzyme present in the liver and the kidneys. In addition, dapagliflozin has been shown to cause weight loss and decrease the risk of cardiovascular events such as congestive heart failure.Fórmula:C21H25ClO6Pureza:Min. 98 Area-%Cor e Forma:White Yellow PowderPeso molecular:408.87 g/mol
